Patents by Inventor John MacDougall

John MacDougall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12029794
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Grant
    Filed: December 2, 2021
    Date of Patent: July 9, 2024
    Assignees: Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Serv.
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • Publication number: 20240216527
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Application
    Filed: March 14, 2024
    Publication date: July 4, 2024
    Applicants: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Serv.
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • Patent number: 11806406
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Grant
    Filed: August 5, 2021
    Date of Patent: November 7, 2023
    Assignees: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • Publication number: 20220387619
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Application
    Filed: August 5, 2021
    Publication date: December 8, 2022
    Applicants: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Serv.
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • Publication number: 20220088216
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Application
    Filed: December 2, 2021
    Publication date: March 24, 2022
    Applicants: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Servic
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • Publication number: 20210393797
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Application
    Filed: August 5, 2021
    Publication date: December 23, 2021
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • Patent number: 11110181
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Grant
    Filed: January 31, 2020
    Date of Patent: September 7, 2021
    Assignees: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • Publication number: 20200188529
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Application
    Filed: January 31, 2020
    Publication date: June 18, 2020
    Applicants: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Servic
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • Publication number: 20200158480
    Abstract: Cartridges and cartridge cases adapted to be chambered in weapon systems are provided. In one example, a cartridge case includes a front shell having a case base end portion, a case body portion extending forward from the case base end portion towards a case mouth portion that is configured for holding a projectile. The case base end portion has a first interlocking feature. A reinforcing cap is disposed adjacent to the case base end portion on a side opposite the internal volume. The reinforcing cap has an annular extraction groove, a primer pocket, a flash hole for providing fluid communication between the primer pocket and the internal volume, and a second interlocking feature that engages the first interlocking feature to couple the reinforcing cap to the case base end portion.
    Type: Application
    Filed: November 14, 2019
    Publication date: May 21, 2020
    Inventors: Yann Routhier, John MacDougall
  • Patent number: 10588984
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Grant
    Filed: September 26, 2018
    Date of Patent: March 17, 2020
    Assignees: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • Publication number: 20190083647
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Application
    Filed: September 26, 2018
    Publication date: March 21, 2019
    Applicants: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Ser.
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • Patent number: 10117947
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Grant
    Filed: September 18, 2014
    Date of Patent: November 6, 2018
    Assignees: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • Publication number: 20170267750
    Abstract: The invention described herein is related to antibodies directed to the antigen TIM-1 and uses of such antibodies for the treatment of cancer (e.g., renal and ovarian cancer). In particular, there are provided fully human monoclonal antibodies directed to the antigen TIM-1. Isolated polynucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions (FR's) and/or complementarity determining regions (CDR's), specifically from FR1 through FR4 or CDR1 through CDR3, are provided. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies are also provided.
    Type: Application
    Filed: March 22, 2017
    Publication date: September 21, 2017
    Inventors: Kam Fai Tse, Vincent A. Pollack, John MacDougall, Suresh G. Shenoy, Traci Mansfield, Henri Lichenstein, Michael E. Jeffers, William J. LaRochelle
  • Publication number: 20160228568
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Application
    Filed: September 18, 2014
    Publication date: August 11, 2016
    Applicants: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Serv
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • Patent number: 8446572
    Abstract: Described herein is an improved sensing system (30) and its method of operation. The system (30) includes a camera (16) for viewing an external scene, the camera comprising one or more detector(s) and has a field of view (40) which overlaps with the path (32) of a pulsed laser (12). The laser path (32) and radiation from the scene viewed (40) share a beamsplitter (36) and a window (38). In order to substantially reduce back-scattered radiation from the laser path (32) affecting operation of the detector(s) of the camera (16), the detector(s) is (are) switched in accordance with the operation of the laser (12) to be “off” or non-receiving when the laser (12) is “on” or firing.
    Type: Grant
    Filed: November 24, 2004
    Date of Patent: May 21, 2013
    Assignee: Selex Galileo Ltd.
    Inventor: John MacDougall
  • Publication number: 20120019814
    Abstract: Described herein is an improved sensing system (30) and its method of operation. The system (30) includes a camera (16) for viewing an external scene, the camera comprising one or more detector(s) and has a field of view (40) which overlaps with the path (32) of a pulsed laser (12). The laser path (32) and radiation from the scene viewed (40) share a beamsplitter (36) and a window (38). In order to substantially reduce back-scattered radiation from the laser path (32) affecting operation of the detector(s) of the camera (16), the detector(s) is (are) switched in accordance with the operation of the laser (12) to be ‘off’ or non-receiving when the laser (12) is ‘on’ or firing.
    Type: Application
    Filed: November 24, 2004
    Publication date: January 26, 2012
    Inventor: John MacDougall
  • Patent number: 7980180
    Abstract: A jacketed projectile having one-piece steel core provides good performance regarding chamber pressure, barrel wear and accuracy by separating the jacket from a central tapered portion of the core by providing an encircling air gap that facilitates engraving of the jacket during firing.
    Type: Grant
    Filed: February 23, 2005
    Date of Patent: July 19, 2011
    Assignee: General Dynamics Ordnance and Tactical Systems-Canada Inc.
    Inventor: John MacDougall
  • Publication number: 20100297118
    Abstract: Provided are methods for treating non-small cell lung cancer by administering a therapeutically effective amount of a hedgehog inhibitor.
    Type: Application
    Filed: April 16, 2010
    Publication date: November 25, 2010
    Inventors: John MacDougall, Kip A. West
  • Publication number: 20090181997
    Abstract: The invention is directed to use of hedgehog inhibitors in conjunction with chemotherapy in treating cancers, and preventing relapses thereby.
    Type: Application
    Filed: December 23, 2008
    Publication date: July 16, 2009
    Inventors: David GRAYZEL, Robert Ross, John MacDougall
  • Publication number: 20080171046
    Abstract: Disclosed herein are novel human nucleic acid sequences which encode polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: May 12, 2004
    Publication date: July 17, 2008
    Inventors: Corine Vermet, Elma Fernandes, Richard Shimkets, John Herrmann, Kumud Majumder, John MacDougall, Vishnu Mishra, Peter S. Mezes, Luca Rastelli